GR1000465B - Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιεχουν ακετυλ d-καρνιτινη για την θεραπευτικη αγωγη του γλαυκωματος. - Google Patents

Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιεχουν ακετυλ d-καρνιτινη για την θεραπευτικη αγωγη του γλαυκωματος.

Info

Publication number
GR1000465B
GR1000465B GR890100797A GR890100797A GR1000465B GR 1000465 B GR1000465 B GR 1000465B GR 890100797 A GR890100797 A GR 890100797A GR 890100797 A GR890100797 A GR 890100797A GR 1000465 B GR1000465 B GR 1000465B
Authority
GR
Greece
Prior art keywords
carnitine
acetyl
glaucoma
pharmaceutical compositions
therapeutic treatment
Prior art date
Application number
GR890100797A
Other languages
English (en)
Other versions
GR890100797A (en
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of GR890100797A publication Critical patent/GR890100797A/el
Publication of GR1000465B publication Critical patent/GR1000465B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Abstract

Περιγράφεται η χρήσις ακετυλο D-καρνιτίνης και των φαρμακολογικώς παραδεκτών αλάτων της εις την θεραπευτικήν αγωγήν του γλαυκώματος. Το φάρμακον ημπορεί να χορηγηθή από του στόματος ή παρεντερικώς ή να εφαρμοσθή ως κολλύριον το οποίον περιέχει περίπου 1-10% β/ό ακετυλο D-καρνιτίνην. ω
GR890100797A 1988-12-01 1989-12-01 Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιεχουν ακετυλ d-καρνιτινη για την θεραπευτικη αγωγη του γλαυκωματος. GR1000465B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8848614A IT1224795B (it) 1988-12-01 1988-12-01 Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento

Publications (2)

Publication Number Publication Date
GR890100797A GR890100797A (en) 1991-03-15
GR1000465B true GR1000465B (el) 1992-07-30

Family

ID=11267644

Family Applications (1)

Application Number Title Priority Date Filing Date
GR890100797A GR1000465B (el) 1988-12-01 1989-12-01 Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιεχουν ακετυλ d-καρνιτινη για την θεραπευτικη αγωγη του γλαυκωματος.

Country Status (13)

Country Link
US (2) US5145871A (el)
EP (1) EP0446268B1 (el)
JP (1) JP2763400B2 (el)
KR (1) KR950004885B1 (el)
AU (1) AU628116B2 (el)
CA (1) CA2004239C (el)
DK (1) DK175891B1 (el)
ES (1) ES2040106T3 (el)
GR (1) GR1000465B (el)
IE (1) IE62568B1 (el)
IT (1) IT1224795B (el)
WO (1) WO1990006111A1 (el)
ZA (1) ZA899176B (el)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
DK0951909T4 (da) 1998-03-19 2011-01-24 Sigma Tau Ind Farmaceuti Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
AU2001237939A1 (en) * 2000-02-08 2001-08-20 Gulgun Tezel Methods for treating glaucoma
ES2340260T3 (es) * 2001-07-06 2010-06-01 Basf Se Procesos para la preparacion de derivados de acido 7-amino sin 3,5-diodroxi heptanoico, intermedios de los mismos y metodos para su preparacion.
US7405192B2 (en) 2001-10-31 2008-07-29 Alcon, Inc. Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma
ITRM20020492A1 (it) * 2002-10-01 2004-04-02 Sigma Tau Ind Farmaceuti Uso della propionil l-carnitina per la preparazione di un medicamento per il trattamento del glaucoma.
WO2004071458A2 (en) * 2003-02-13 2004-08-26 Albert Einstein College Of Medicine Of Yeshiva University REGULATION OF FOOD INTAKE AND GLUCOSE PRODUCTION BY MODULATION OF LONG-CHAIN FATTY ACYL-CoA LEVELS IN THE HYPOTHALAMUS
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US6951658B1 (en) 2003-07-08 2005-10-04 Pearson Research & Development Limited Emu-based compositions for mental well-being and method of use
US7718697B2 (en) * 2003-12-17 2010-05-18 Alcon, Inc. Method for treating glaucoma comprising administering α-lipoic acid
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US8168206B1 (en) 2005-10-06 2012-05-01 Allergan, Inc. Animal protein-free pharmaceutical compositions
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
EP2363126A1 (en) 2010-03-04 2011-09-07 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation
US9114120B2 (en) 2010-11-22 2015-08-25 Sigma-Tau Industrie Farmaceutiche Riunite, S.P.A. Therapeutical method for the treatment of the Leber optic neuropathy
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
KR102017922B1 (ko) 2011-12-07 2019-09-03 알러간, 인코포레이티드 염-민감성 유액 시스템을 사용한 사람 눈물막으로의 효율적인 지질 전달 방법
EP2783695A1 (en) 2013-03-28 2014-10-01 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin
MX2017006474A (es) 2014-11-25 2017-09-12 Allergan Inc Composiciones oftalmicas estabilizadas de omega 3.
IT201900002913A1 (it) 2019-03-01 2020-09-01 Nicola Pescosolido Composto utile per il trattamento del glaucoma
IT202100020729A1 (it) 2021-08-02 2023-02-02 Univ Degli Studi Di Napoli Federico Ii Preparazione combinata per il trattamento della malattia di Pompe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1262864A (en) * 1982-09-17 1989-11-14 Clarence D. Cone Method for producing oncolysis

Also Published As

Publication number Publication date
DK95091D0 (da) 1991-05-21
EP0446268B1 (en) 1993-04-14
JPH04502161A (ja) 1992-04-16
IE62568B1 (en) 1995-02-08
ZA899176B (en) 1990-09-26
JP2763400B2 (ja) 1998-06-11
IT1224795B (it) 1990-10-24
AU4658489A (en) 1990-06-26
GR890100797A (en) 1991-03-15
KR920702216A (ko) 1992-09-03
DK95091A (da) 1991-05-21
KR950004885B1 (ko) 1995-05-15
ES2040106T3 (es) 1993-10-01
IE893840L (en) 1990-06-01
US5145871A (en) 1992-09-08
AU628116B2 (en) 1992-09-10
WO1990006111A1 (en) 1990-06-14
US5432199A (en) 1995-07-11
EP0446268A1 (en) 1991-09-18
CA2004239C (en) 1999-11-09
IT8848614A0 (it) 1988-12-01
CA2004239A1 (en) 1990-06-01
DK175891B1 (da) 2005-05-30

Similar Documents

Publication Publication Date Title
GR1000465B (el) Μεθοδος παρασκευης φαρμακευτικων συνθεσεων που περιεχουν ακετυλ d-καρνιτινη για την θεραπευτικη αγωγη του γλαυκωματος.
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
FI940787A (fi) Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE69212882D1 (de) Gallensäuresalze enthaltende magenstabile pharmazeutische Zusammensetzung zur oralen Verabreichung
ES554967A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
DE69212879T2 (de) Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
ATE99172T1 (de) Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung.
GB9212450D0 (en) New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
IT1244636B (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
GR1000419B (el) Μορφη δοσολογιας για χορηγηση ανταγωνιστη του ασβεστιου.
DE69115476D1 (de) Arzneimittel
ATE22879T1 (de) Pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
ES2096203T3 (es) Nuevos derivados de fisostigmina, su uso y formulaciones farmaceuticas que los contienen.
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
DE69026295T2 (de) Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция
HUP0104619A2 (hu) PDE inhibitorok alkalmazása húgyhólyagbetegségek kezelésére szolgáló gyógyszerkészítmény előállítására
AR014096A1 (es) 17 alfa,8,9-deshidroestradiol y 17 beta delta 8,9 deshidroestradiol, el uso de los mismos para la manufactura de un medicamento, una composicionfarmaceutica que los comprende y un procedimiento para su preparacion.
IT8921908A0 (it) Forma di somministrazione orale del fosfato di creatina e relative composizioni farmaceutiche

Legal Events

Date Code Title Description
MA Right expired